Sun Pharma Appoints Aalok Shanghvi as COO
Sun Pharmaceutical Industries has elevated Aalok Shanghvi, son of MD Dilip Shanghvi, as its new Chief Operating Officer. Shanghvi has been with the company since 2006 and has held various roles in marketing, R&D, and business development.
Photograph: Francis Mascarenhas/Reuters
New Delhi, Feb 3 (PTI) Sun Pharma on Monday said it has elevated Aalok Shanghvi as Chief Operating Officer.
He is currently designated as Whole-time Director and Executive Vice-President, Emerging Markets, Global Generic R&D, Global Business Development (Generics), Operations and API.
Shanghvi, son of Sun Pharma MD Dilip Shanghvi, joined Sun Pharma in 2006 and has handled various roles in marketing, R&D, project management, purchase and communications, the Mumbai-based drug major said in a regulatory filing.
In 2014, he became the Head of Emerging Markets business, spread across 80 countries covering Africa, the Middle East, APAC, Eastern Europe, CIS, and Latam.
He is currently designated as Whole-time Director and Executive Vice-President, Emerging Markets, Global Generic R&D, Global Business Development (Generics), Operations and API.
Shanghvi, son of Sun Pharma MD Dilip Shanghvi, joined Sun Pharma in 2006 and has handled various roles in marketing, R&D, project management, purchase and communications, the Mumbai-based drug major said in a regulatory filing.
In 2014, he became the Head of Emerging Markets business, spread across 80 countries covering Africa, the Middle East, APAC, Eastern Europe, CIS, and Latam.
You May Like To Read
MORE NEWS
© 2025 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback